Mounjaro® is a once-weekly injectable medication used for weight management. Its active ingredient, tirzepatide, is a dual receptor agonist that acts on both GIP (glucose-dependent insulinotropic polypeptide receptor) and GLP-1 (glucagon-like peptide-1 receptor) in the body. This innovative dual-action mechanism may help reduce body weight, improve insulin sensitivity, and support internal fat metabolism.

Before use, a doctor’s consultation is required to assess your health condition and determine a suitable treatment plan. Additional medical tests may be required.

Mounjaro® has been approved by the U.S. FDA for the treatment of type 2 diabetes and has shown promising weight management results in clinical studies, making it a newer option in the field of weight management medication.

Mounjaro® | GIP and GLP-1 Dual Receptor Agonist | Tirzepatide | Weight Loss Pen | 100% Authentic

Name: Mounjaro® | GIP and GLP-1 Dual Receptor Agonist | Tirzepatide | Weight Loss Pen | 100% Authentic
Brand: Lily
SKU: FM-MOUNJ-PEN-PARENT

HK$3,399.00

選擇劑量

Quantity

2.5mg:HK-68411
5mg:HK-68412
7.5mg:HK-68413
10mg:HK-68408
Who may be suitable for Mounjaro®?

Mounjaro® may be suitable for people who:

Have tried different weight management methods without satisfactory results

Have limited time to plan diet and exercise routines

Tend to have a large appetite or frequent snacking habits

Experience postnatal weight gain, middle-aged weight gain, or reduced metabolism

Are affected by high blood pressure, high blood sugar, high cholesterol, or metabolic syndrome

Prefer injections over oral medication, or have difficulty swallowing tablets

A doctor’s assessment is required before use to determine whether Mounjaro® is suitable for your health condition.

Who may not be suitable for Mounjaro®?

Mounjaro® may not be suitable for people who:

Are pregnant or breastfeeding

Are allergic to any of its ingredients

Have severe gastrointestinal diseases

Have medullary thyroid carcinoma (MTC) or a related medical history

Have severe kidney or liver impairment
Mounjaro® is injected once weekly and can be used at any time of the day. However, it is recommended to inject it at a consistent time each week. It is not affected by meal times.

Mounjaro® is a subcutaneous injection. The recommended injection areas are the front of the abdomen, the outer thigh, or the upper arm.

Prepare the injection pen: Take out the injection pen, check that the solution is clear and free from particles, then attach a new needle.

Set the dose: Turn the dose selector to the dose instructed by your doctor.

Clean the injection site: Use an alcohol swab to clean the injection area.

Inject the medication: Insert the needle vertically into the skin and press the button until the indicator window shows that the injection is complete.

Hold for a few seconds: Keep the needle under the skin for around 6 seconds after injection to ensure the full dose has been delivered.

Dispose of the needle: Remove the used needle immediately after use and dispose of it properly in a sharps container.
Mounjaro® is a prescription medication and may cause the following common side effects, which are usually mild and more common during the initial adjustment period:

Nausea or vomiting

Diarrhoea or constipation

Dizziness or tiredness

Reduced appetite

Mild redness or swelling at the injection site

These symptoms usually appear at the beginning of treatment. As the body adjusts to the medication, most users may find that the symptoms gradually improve.

Rare but serious side effects may involve gallbladder disease or pancreatitis. Therefore, close monitoring is required during treatment, and medical advice should be sought promptly when needed.

If you experience any side effects, especially if the symptoms are severe or persistent, please consult your doctor.